ATE521602T1 - Benzothiophen-2-carbonylguanidinderivate, deren herstellung und pharmazeutische zusammensetzung, die diese enthält - Google Patents

Benzothiophen-2-carbonylguanidinderivate, deren herstellung und pharmazeutische zusammensetzung, die diese enthält

Info

Publication number
ATE521602T1
ATE521602T1 AT05822428T AT05822428T ATE521602T1 AT E521602 T1 ATE521602 T1 AT E521602T1 AT 05822428 T AT05822428 T AT 05822428T AT 05822428 T AT05822428 T AT 05822428T AT E521602 T1 ATE521602 T1 AT E521602T1
Authority
AT
Austria
Prior art keywords
derivatives
models
ischemic
preparation
significantly reduce
Prior art date
Application number
AT05822428T
Other languages
English (en)
Inventor
Kyu Yang Yi
Sunkyung Lee
Jee Hee Suh
Nak Jeong Kim
Hyunsuk Lee
Byung-Ho Lee
Sung-Eun Yoo
Kyung-Hee Lee
Yong Oh Lee
Original Assignee
Korea Res Inst Chem Tech
Yuyu Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Korea Res Inst Chem Tech, Yuyu Inc filed Critical Korea Res Inst Chem Tech
Application granted granted Critical
Publication of ATE521602T1 publication Critical patent/ATE521602T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/72—Benzo[c]thiophenes; Hydrogenated benzo[c]thiophenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D333/70—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT05822428T 2004-12-27 2005-12-27 Benzothiophen-2-carbonylguanidinderivate, deren herstellung und pharmazeutische zusammensetzung, die diese enthält ATE521602T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20040112856 2004-12-27
PCT/KR2005/004573 WO2006071047A1 (en) 2004-12-27 2005-12-27 Benzothiophen-2-carbonylguanidine derivatives, preparation thereof, and pharmaceutical composition containing the same

Publications (1)

Publication Number Publication Date
ATE521602T1 true ATE521602T1 (de) 2011-09-15

Family

ID=36615133

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05822428T ATE521602T1 (de) 2004-12-27 2005-12-27 Benzothiophen-2-carbonylguanidinderivate, deren herstellung und pharmazeutische zusammensetzung, die diese enthält

Country Status (10)

Country Link
US (1) US8143307B2 (de)
EP (1) EP1831192B1 (de)
JP (1) JP4975641B2 (de)
KR (1) KR100658698B1 (de)
CN (1) CN101137641B (de)
AT (1) ATE521602T1 (de)
AU (1) AU2005320415B2 (de)
CA (1) CA2594221C (de)
IL (1) IL184231A0 (de)
WO (1) WO2006071047A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100840686B1 (ko) * 2007-04-16 2008-06-24 한국화학연구원 헤테로고리를 포함하는 카보닐구아니딘 유도체를유효성분으로 함유하는 ｂａｆｆ 매개성 질환의 예방 및치료용 약학적 조성물
JP5929483B2 (ja) * 2011-05-10 2016-06-08 住友化学株式会社 植物の生長を促進する方法
JP5929482B2 (ja) * 2011-05-10 2016-06-08 住友化学株式会社 植物の生長を促進する方法
CA2820331C (en) 2012-06-19 2017-11-07 Eddie Leach Do-it-yourself fence
CA2890431A1 (en) 2012-11-09 2014-05-15 Sumitomo Chemical Company, Limited Method for promoting plant growth
BR112015010478A2 (pt) * 2012-11-09 2017-07-11 Sumitomo Chemical Co método para a promoção do crescimento de planta

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5340833A (en) * 1992-05-01 1994-08-23 Eisai Co., Ltd. Urokinase inhibitors
EP0639573A1 (de) * 1993-08-03 1995-02-22 Hoechst Aktiengesellschaft Benzokondensierte 5-Ringheterocyclen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, ihre Verwendung als Diagnostikum, sowie sie enthaltendes Medikament
DE4430861A1 (de) 1994-08-31 1996-03-07 Merck Patent Gmbh Heterocyclyl-benzoylguanidine
JPH09278767A (ja) * 1996-02-15 1997-10-28 Fujisawa Pharmaceut Co Ltd 新規グアニジン誘導体
AUPO545297A0 (en) 1997-03-04 1997-03-27 Fujisawa Pharmaceutical Co., Ltd. Guanidine derivatives
EP1456181A1 (de) * 2001-12-19 2004-09-15 Pfizer Products Inc. Verfahren zur herstellung von typ-1 natrium-wasserstoff-austauscher (oder nhe-1)- inhibitoren

Also Published As

Publication number Publication date
EP1831192B1 (de) 2011-08-24
WO2006071047A1 (en) 2006-07-06
US8143307B2 (en) 2012-03-27
US20100004466A1 (en) 2010-01-07
CN101137641A (zh) 2008-03-05
AU2005320415B2 (en) 2009-12-03
CA2594221A1 (en) 2006-07-06
JP4975641B2 (ja) 2012-07-11
CA2594221C (en) 2010-09-21
EP1831192A4 (de) 2009-08-19
KR20060074894A (ko) 2006-07-03
CN101137641B (zh) 2010-11-24
EP1831192A1 (de) 2007-09-12
IL184231A0 (en) 2007-10-31
JP2008525523A (ja) 2008-07-17
AU2005320415A1 (en) 2006-07-06
KR100658698B1 (ko) 2006-12-19

Similar Documents

Publication Publication Date Title
ATE521602T1 (de) Benzothiophen-2-carbonylguanidinderivate, deren herstellung und pharmazeutische zusammensetzung, die diese enthält
BRPI0515482A (pt) derivados heterocìclicos e seus usos como agentes terapêuticos
AR031430A1 (es) Compuestos de bisarilo orto, meta-sustituidos, procedimientos para su preparacion, su utilizacion como medicamento como tambien los preparados farmaceuticos que los contienen
MY134641A (en) Indolinephenylsulphonamide derivatives
WO2007071963A3 (en) Quinazoline derivatives, process for their preparation and their use as anti-cancer agents
NO20060981L (no) Pyridazinderivater og deres anvendelse som terapeutiske midler
KR101894004B1 (ko) NamPT 억제용 신규 화합물 및 이를 포함하는 조성물
BR0210711A (pt) Uso de um composto, composição farmacêutica, composto, e, processo para a preparação de um composto
ES2282685T3 (es) Derivados de hidroxietilamina para el tratamiento de la enfermedad de alzheimer.
BRPI0416212A (pt) derivado de piridazinona, composição farmacêutica, uso do derivado, método para o tratamento de um sujeito afligido com uma condição ou doença susceptìvel de melhora pela inibição de fosfodiesterase 4 e produto de combinação
DK1706403T3 (da) Imidazo[4,5-c]pyridinforbindelser og fremgangsmåder til antiviral behandling
TW200500358A (en) Compounds
CA2534571A1 (en) Substituted isoquinoline derivatives and methods of use
CY1112958T1 (el) Ιατρικες συνθεσεις που περιλαμβανουν τακρινη ή ντονεπεζιλη για βελτιωση εγκεφαλικης λειτουργιας
BR0312232A (pt) Inibidores de caspases e seus usos
NO20063137L (no) Tricykliske indolhydroksyetylaminderivater og deres anvendelse i behandlingen av Alzheimers sykdom
ECSP045469A (es) El uso de cianopirrolidinas sustituidas y preparaciones de combinacion que las contienen para tratar hiperlipidemia y enfermedades asociadas
EP1689713A4 (de) Benzylether und benzylaminoverbindungen als inhibitoren von beta-secretase zur behandlung von alzheimer-krankheit
UY29239A1 (es) Nuevos derivados de piridotienopirimidina
WO2006108679A3 (en) Substances and pharmaceutical compositions for the inhibition of glyoxalases and their use to combat cancer
UY30014A1 (es) Subgrupo de compuestos basados en oxabispidina comprendiendo un grupo alquilo amidasustituido, proceso de preparación, composiciones farmacéuticas conteniéndolos y aplicaciones
BR0315462A (pt) Composto, composição farmacêutica, uso de um composto, método para o tratamento de um sujeito que sofre de uma condição patológica ou de doença susceptìvel de alìvio por antagonismo de receptores de ltd4 e produto de combinação
WO2007019078A3 (en) Tricyclic beta-secretase inhibitors for the treatment of alzheimer's disease
AR024292A1 (es) INHIBIDORES DE FACTOR VIIA, UN PROCESO PARA SU PREPARACIoN, UNA COMPOSICIoN FARMACÉUTICA Y USO DE LOS MISMOS PARA LA MANUFACTURA DE UN MEDICAMENTO PARA REDUCIR LA COAGULACIoN EN SANGRE O RESPUESTA INFLAMATORIA DESoRDENES CARDIOVASCULARES, ENFERMEDADES TROMBOEMBOLíTICAS O RESTENOSIS.
AU2018205277A1 (en) Small molecule inhibitors of neutral sphingomyelinase 2 (nSMase2) for the treatment of neurodegenerative diseases

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties